DCSVX
Price
$11.68
Change
+$0.06 (+0.52%)
Updated
Jan 17 closing price
Net Assets
104.77M
SSGSX
Price
$47.63
Change
+$0.07 (+0.15%)
Updated
Jan 17 closing price
Net Assets
6.68B
Ad is loading...

DCSVX vs SSGSX

Header iconDCSVX vs SSGSX Comparison
Open Charts DCSVX vs SSGSXBanner chart's image
Dunham Small Cap Value C
Price$11.68
Change+$0.06 (+0.52%)
VolumeN/A
Net Assets104.77M
Victory Sycamore Small Company Opp A
Price$47.63
Change+$0.07 (+0.15%)
VolumeN/A
Net Assets6.68B
DCSVX vs SSGSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DCSVX vs. SSGSX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCSVX is a Buy and SSGSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 6.68B vs. DCSVX (105M). SSGSX pays higher dividends than DCSVX: SSGSX (0.35) vs DCSVX (0.00). DCSVX was incepted earlier than SSGSX: DCSVX (20 years) vs SSGSX (26 years). DCSVX is a more actively managed with annual turnover of: 95.00 vs. SSGSX (32.00). SSGSX has a lower initial minimum investment than DCSVX: SSGSX (2500) vs DCSVX (5000). SSGSX annual gain was more profitable for investors over the last year : 5.32 vs. DCSVX (-1.73). SSGSX return over 5 years is better than : 6.54 vs. DCSVX (-9.41).
DCSVXSSGSXDCSVX / SSGSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years26 years-
Gain YTD2.2772.58588%
Front LoadN/AN/A-
Min. Initial Investment50002500200%
Min. Initial Investment IRAN/AN/A-
Net Assets105M6.68B2%
Annual Yield % from dividends0.000.35-
Returns for 1 year-1.735.32-33%
Returns for 3 years-17.72-5.92299%
Returns for 5 years-9.416.54-144%
Returns for 10 years-12.0730.62-39%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EAPR25.950.14
+0.53%
Innovator Em Mkts Pwr Bffr ETF - Apr
IBHH23.580.04
+0.16%
iShares iBonds 2028 Term HY & Inc ETF
LMBS48.720.02
+0.04%
First Trust Low Duration Oppos ETF
TTAC69.35N/A
N/A
FCF US Quality ETF
CNCR11.67-0.03
-0.26%
Range Cancer Therapeutics ETF